Wabash Announces Second Quarter 2024 Results
Quarterly revenue of $551 million; within prior quarterly outlook range Operating income of $44 million with operating margin of 7.9% […]
Quarterly revenue of $551 million; within prior quarterly outlook range Operating income of $44 million with operating margin of 7.9% […]
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of […]
VANCOUVER, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) […]
Miami, FL, July 24, 2024 (GLOBE NEWSWIRE) — Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 […]
CHANTILLY, Va., July 24, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN), a leader in infrastructure, defense, security, transportation, and […]
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today […]
LAS VEGAS, July 24, 2024 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the […]
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to […]
SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on […]
SOUTH SAN FRANCISCO, Calif., July 24, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural […]